Skip to main content
Watch Insiders
EBSHealthcare

Emergent Biosolutions Inc (EBS) Insider Trading

In the last 90 days, 2 Emergent Biosolutions Inc (EBS) insiders reported no open-market purchases and 2 sales totaling $145,792. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 7, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 7, 2026Donald W DeGolyerCorporate insiderSale17,800$7.09$126,202
Oct 1, 2026Paul Anthony WilliamsSVP, Products BusinessSale3,000$6.53$19,590
Jul 1, 2026Paul Anthony WilliamsSVP, Products BusinessSale3,000$8.40$25,200
May 1, 2026Kathryn C ZoonCorporate insiderSale17,202$8.40$144,454
May 1, 2026Donald W DeGolyerCorporate insiderSale15,481$8.40$129,994
May 1, 2026Sujata Tyagi DayalCorporate insiderSale13,761$8.40$115,610
Apr 30, 2026Keith KatkinCorporate insiderSale15,481$8.28$128,183

Common questions

EBS insider trading FAQ

Are EBS insiders buying or selling?
Over the last 90 days, EBS insiders were net sellers, reporting $0.00 of open-market purchases and $145,792 of sales.
When was the last EBS insider purchase?
No open-market insider purchase of Emergent Biosolutions Inc stock was reported in the last 90 days.
Where does EBS insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Emergent Biosolutions Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.